StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
71
This month
3
This week
1
This year
6
Yesterday
1
Publishing Date
2023 - 12 - 27
2
2023 - 11 - 30
1
2023 - 11 - 22
1
2023 - 11 - 08
1
2023 - 09 - 06
1
2023 - 08 - 08
1
2023 - 07 - 14
1
2023 - 06 - 27
1
2023 - 06 - 06
1
2023 - 06 - 05
1
2023 - 05 - 31
1
2023 - 05 - 05
1
2023 - 04 - 20
1
2023 - 04 - 17
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2023 - 03 - 02
1
2023 - 03 - 01
1
2023 - 01 - 17
1
2023 - 01 - 11
1
2023 - 01 - 09
2
2022 - 12 - 05
1
2022 - 11 - 16
1
2022 - 10 - 24
1
2022 - 10 - 14
1
2022 - 09 - 19
1
2022 - 08 - 23
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 20
1
2022 - 07 - 18
1
2022 - 07 - 14
1
2022 - 07 - 04
1
2022 - 06 - 22
1
2022 - 06 - 21
1
2022 - 06 - 15
1
2022 - 06 - 13
1
2022 - 04 - 26
1
2022 - 02 - 23
1
2022 - 02 - 04
1
2022 - 01 - 28
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 14
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 08
1
2021 - 12 - 02
1
2021 - 11 - 30
1
2021 - 11 - 24
1
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 01
1
2021 - 10 - 21
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 09 - 22
2
2021 - 09 - 20
1
2021 - 09 - 09
2
2021 - 09 - 07
1
Sector
Energy minerals
1
Health technology
71
Tags
Acquisition
2
Agreement
2
Als
8
Application
3
Approval
1
Australia
1
Biocanada
6
Cancer
2
Capacity
1
Care
1
Ceo
3
Chinese
2
Chronic cough
5
Clinical-trials-phase-ii
6
Conference
5
Depression
1
Designation
2
Disease
2
Drug
9
Enroll
2
Events
1
Fda
6
Fibrosis
6
Financial
1
For
1
Global
1
Grant
3
Group
1
Growth
1
Intel
1
Ipo
1
Japan
1
Kidney
2
Liver
1
Lung cancer
2
Management
1
Money
2
N/a
40
Nash
4
Neurological
1
Offering
5
Ongoing
1
Patent
10
People
3
Pharmaceutical
6
Pharmaceuticals
28
Phase 1
6
Phase 2
19
Phase 2b
4
Phase 3
2
Positive
4
Pre-clinical
2
Preclinical
2
Program
5
Research
12
Stroke
11
Study
11
Treat
2
Treatment
7
Trial
3
Entities
Algernon pharmaceuticals inc.
71
Genoil inc
1
Medicure inc
1
Sanofi
1
Symbols
A
429
ABBV
1030
ABT
1797
ALPMF
334
ALPMY
334
AMGN
744
AZN
668
AZNCF
451
BAX
484
BDX
796
BGNE
325
BHC
389
BIIB
382
BIO
449
BMY
664
BNTX
368
BSX
577
BWAY
331
DHR
786
FNCTF
493
GILD
501
GLAXF
661
GMAB
298
GOOG
308
GOOGL
309
GSK
887
HEPA
404
HOLX
328
ILMN
451
INCY
445
JNJ
4608
LLY
1712
MDT
1286
MOR
320
MPSYF
276
MRK
338
MRNA
352
MS
623
NKTR
371
NVO
636
NVS
1245
NVSEF
1035
OCX
487
PFE
693
PHG
963
PKI
274
PRVB
348
PTCT
271
QGEN
370
REGN
423
RYLPF
440
SNY
4566
SNYNF
3624
SYK
536
TAK
424
TEVJF
633
TMO
1630
TXMD
283
VTRS
365
VXRT
319
Exchanges
Nasdaq
71
Crawled Date
2023 - 12 - 27
2
2023 - 11 - 30
1
2023 - 11 - 22
1
2023 - 11 - 08
1
2023 - 09 - 06
1
2023 - 08 - 08
1
2023 - 07 - 14
1
2023 - 06 - 27
1
2023 - 06 - 06
1
2023 - 06 - 05
1
2023 - 05 - 31
1
2023 - 05 - 05
1
2023 - 04 - 20
1
2023 - 04 - 17
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2023 - 03 - 02
1
2023 - 03 - 01
1
2023 - 01 - 17
1
2023 - 01 - 11
1
2023 - 01 - 09
2
2022 - 12 - 05
1
2022 - 11 - 16
1
2022 - 10 - 24
1
2022 - 10 - 14
1
2022 - 09 - 19
1
2022 - 08 - 23
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 20
1
2022 - 07 - 18
1
2022 - 07 - 14
1
2022 - 07 - 04
1
2022 - 06 - 22
1
2022 - 06 - 21
1
2022 - 06 - 15
1
2022 - 06 - 13
1
2022 - 04 - 26
1
2022 - 02 - 23
1
2022 - 02 - 04
1
2022 - 01 - 28
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 14
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 08
1
2021 - 12 - 02
1
2021 - 11 - 30
1
2021 - 11 - 24
1
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 01
1
2021 - 10 - 21
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 09 - 22
2
2021 - 09 - 20
1
2021 - 09 - 09
2
2021 - 09 - 07
1
Crawled Time
01:00
1
02:00
1
03:00
1
11:00
8
12:00
20
12:15
1
12:20
3
12:30
2
13:00
4
13:20
1
14:00
3
14:20
2
15:00
3
15:20
2
16:00
3
17:00
2
19:00
7
20:00
1
21:00
4
22:00
1
23:00
1
Source
www.algernonpharmaceuticals.com
3
www.biospace.com
31
www.globenewswire.com
37
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
symbols :
AGNPF
save search
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
Published:
2024-04-24
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
0.0%
|
O:
0.0%
H:
0.0%
C:
0.0%
drug
conference
stroke
research
for
Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
25.87%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ceo
pharmaceuticals
Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
Published:
2024-04-01
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
9.76%
|
O:
0.37%
H:
4.5%
C:
-11.69%
drug
stroke
pharmaceuticals
research
program
Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Published:
2024-03-27
(Crawled : 16:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
45.16%
|
O:
25.81%
H:
0.0%
C:
0.0%
acquisition
pharmaceuticals
research
program
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
Published:
2024-01-31
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
50.5%
|
O:
5.02%
H:
13.06%
C:
11.46%
patent
treat
pharmaceuticals
grant
chinese
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
Published:
2024-01-11
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
Email alert
Add to watchlist
patent
japan
fibrosis
pharmaceuticals
Algernon Pharmaceuticals Announces Closing of Private Placement
Published:
2023-12-27
(Crawled : 21:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
80.0%
|
O:
9.2%
H:
20.51%
C:
15.38%
pharmaceuticals
Algernon Pharmaceuticals Announces Increase to Private Placement
Published:
2023-12-27
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
80.0%
|
O:
0.0%
H:
0.0%
C:
0.0%
pharmaceuticals
Algernon Pharmaceuticals Announces Private Placement
Published:
2023-12-13
(Crawled : 01:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
57.89%
|
O:
3.68%
H:
0.0%
C:
-5.92%
pharmaceuticals
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
Published:
2023-11-30
(Crawled : 17:00)
- biospace.com/
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
58.45%
|
O:
12.32%
H:
0.0%
C:
0.0%
patent
treat
pharmaceuticals
grant
chinese
nash
Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Published:
2023-11-22
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
70.45%
|
O:
7.95%
H:
45.61%
C:
24.56%
acquisition
pharmaceuticals
research
program
Algernon Pharmaceuticals Receives Japanese Patent Notice of Allowance for Treatment of NASH with Repirinast
Published:
2023-11-08
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
73.08%
|
O:
-8.27%
H:
0.0%
C:
0.0%
patent
treatment
pharmaceuticals
nash
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH
Published:
2023-09-06
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
-20.0%
|
O:
11.11%
H:
1.6%
C:
-4.24%
patent
pharmaceuticals
grant
nash
Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study
Published:
2023-08-08
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
-36.08%
|
O:
-7.67%
H:
0.0%
C:
0.0%
drug
stroke
study
phase 2
Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement
Published:
2023-07-14
(Crawled : 22:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
Email alert
Add to watchlist
pharmaceuticals
financial
agreement
Algernon Pharmaceuticals Engages Maxim Group to Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug Development Program
Published:
2023-06-27
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
-37.97%
|
O:
3.1%
H:
0.94%
C:
-3.21%
drug
group
pharmaceuticals
program
phase 2
Algernon Pharmaceuticals to Present Phase 2 Ifenprodil Cough Data at the 2023 American Cough Conference
Published:
2023-06-06
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
-45.78%
|
O:
8.43%
H:
2.28%
C:
2.28%
conference
pharmaceuticals
phase 2
Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies
Published:
2023-06-05
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
-51.35%
|
O:
0.0%
H:
1.14%
C:
-10.27%
stroke
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office for Repirinast and the Treatment of CKD
Published:
2023-05-31
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
-43.54%
|
O:
-4.89%
H:
0.0%
C:
0.0%
patent
treatment
pharmaceuticals
Algernon Pharmaceuticals Announces Closing of Rights Offering
Published:
2023-05-05
(Crawled : 21:00)
- globenewswire.com
AGNPF
|
$0.089
178.69%
0
|
Health Technology
|
Email alert
Add to watchlist
offering
pharmaceuticals
← Previous
1
2
3
4
Next →
Gainers vs Losers
61%
39%
Top 10 Gainers
BOF
|
$2.08
77.78%
39.06%
110M
|
BHIL
|
$0.1793
-4.37%
19.24%
340K
|
Agriculture, Forestry, Fishing ...
UMAC
|
$1.48
-1.33%
14.87%
20K
|
CI
|
$352.28
-0.11%
13.53%
2
|
Health Services
CIG.C
|
$2.89
-1.37%
12.8%
2.3K
|
n/a
MTH
|
$154.69
-2.21%
12.68%
450K
|
Consumer Durables
HCP
|
News
|
$31.41
7.75%
11.26%
1.2M
|
BMTX
4
|
$1.545
0.98%
10.03%
2.5K
|
Information
TAL
|
$12.26
0.57%
9.22%
12M
|
Consumer Services
ASXC
|
$0.243
-2.41%
7.0%
1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.